Kinnate Biopharma Inc.
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma…
Biotechnology
US, San Francisco [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Kinnate Biopharma Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDKinnate Biopharma Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Kinnate Biopharma Inc..
If you want to see a demo, head over to the financial segments of AAPL